| Blood Pressure and Hypertension Studies | Lifetime | 882 | GR 15 | 97.67 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 973 | GR 7 | 92.71 |
| Heart rate and cardiovascular health | Lifetime | 636 | GR 7 | 70.63 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 28 | GR 2 | 99.44 |
| Heart Rate Variability and Autonomic Control | 2021-2025 | 54 | GR 2 | 97.91 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 206 | GR 1 | 98.38 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 304 | GR 2 | 97.74 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 179 | GR 7 | 93.27 |
| Sodium Intake and Health | 2021-2025 | 47 | GR 1 | 94.69 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 67 | GR 1 | 94.52 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 223 | GR 4 | 95.39 |
| Coronary Interventions and Diagnostics | 2021-2025 | 347 | GR 2 | 96.16 |
| Cardiac Arrhythmias and Treatments | 2021-2025 | 560 | GR 5 | 95.54 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 795 | GR 15 | 94.76 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 259 | GR 14 | 91.93 |
| Heart Failure Treatment and Management | 2021-2025 | 557 | GR 7 | 93.39 |
| Hormonal Regulation and Hypertension | 2021-2025 | 303 | GR 6 | 90.34 |
| Cardiac Health and Mental Health | 2021-2025 | 374 | GR 4 | 90.15 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 697 | GR 3 | 92.85 |
| Infective Endocarditis Diagnosis and Management | 2021-2025 | 695 | GR 4 | 91.47 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 294 | GR 11 | 88.35 |
| Diabetes Treatment and Management | 2021-2025 | 899 | GR 19 | 91.12 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 76 | GR 7 | 85.97 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 711 | GR 7 | 86.42 |
| Acute Myocardial Infarction Research | 2021-2025 | 872 | GR 6 | 90.48 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 664 | GR 3 | 86.62 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 795 | GR 16 | 81.58 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 644 | GR 12 | 80.81 |
| Medication Adherence and Compliance | 2021-2025 | 400 | GR 3 | 81.09 |
| Heart rate and cardiovascular health | 2021-2025 | 42 | GR 1 | 75.32 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 849 | GR 9 | 75.12 |
| Cardiovascular and Diving-Related Complications | 2021-2025 | 368 | GR 7 | 74.01 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | 2021-2025 | 181 | GR 4 | 68.95 |
| Pharmaceutical Economics and Policy | 2021-2025 | 806 | GR 4 | 73.05 |
| Pain Management and Treatment | 2021-2025 | 596 | GR 1 | 71.38 |
| Takotsubo Cardiomyopathy and Associated Phenomena | 2021-2025 | 248 | GR 7 | 68.72 |
| Potassium and Related Disorders | 2021-2025 | 882 | GR 14 | 55.65 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 587 | GR 7 | 50.90 |
